A Phase 1, Open-Label, Parallel-Group, Single-Dose Study To Compare The Pharmakokinetics Of TNX-102 SL (Cyclobenzaprine Hydrochloride Sublingual Tablet) In Non-Elderly Versus Elderly Participants

​ Conditions: Pharmakokinetic; Open Label; Phase 1

Interventions: Drug: TNX-102 SL Tablet

Sponsors: Tonix Pharmaceuticals, Inc.; Syneos Health

Active, not recruiting Conditions: Pharmakokinetic; Open Label; Phase 1
Interventions: Drug: TNX-102 SL Tablet
Sponsors: Tonix Pharmaceuticals, Inc.; Syneos Health
Active, not recruiting